These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12442555)

  • 21. Bedding down costs.
    Cys J
    Mater Manag Health Care; 2003 Apr; 12(4):20-2. PubMed ID: 12854203
    [No Abstract]   [Full Text] [Related]  

  • 22. As technology races for the stars, so do costs.
    Ford RL
    Hosp Mater Manage; 1996 Aug; 21(8):18. PubMed ID: 10159426
    [No Abstract]   [Full Text] [Related]  

  • 23. Price survey. Contracts key to foley stability.
    Hosp Mater Manage; 2002 Aug; 27(8):1, 12-3. PubMed ID: 12232892
    [No Abstract]   [Full Text] [Related]  

  • 24. Price survey. Gown prices head back up.
    Hosp Mater Manage; 2001 Dec; 26(12):1, 12-3. PubMed ID: 11775267
    [No Abstract]   [Full Text] [Related]  

  • 25. IOL prices level off after 3 years.
    Hosp Mater Manage; 1997 Nov; 22(11):1, 10. PubMed ID: 10175298
    [No Abstract]   [Full Text] [Related]  

  • 26. Stats. Bone up on ortho supply prices.
    Mater Manag Health Care; 2000 Jun; 9(6):72. PubMed ID: 11183702
    [No Abstract]   [Full Text] [Related]  

  • 27. Foley prices steady, for now.
    Hosp Mater Manage; 2001 Jun; 26(6):1, 12-3. PubMed ID: 11409206
    [No Abstract]   [Full Text] [Related]  

  • 28. AmeriNet posts inflationary indices.
    Hosp Mater Manage; 1998 Dec; 23(12):16. PubMed ID: 10338815
    [No Abstract]   [Full Text] [Related]  

  • 29. Competition propping up. Second drug-eluting stent will be cheaper, plentiful.
    Becker C
    Mod Healthc; 2004 Mar; 34(11):12. PubMed ID: 15069793
    [No Abstract]   [Full Text] [Related]  

  • 30. PTCA catheters become less costly.
    Hosp Mater Manage; 1999 Feb; 24(2):1, 12-3. PubMed ID: 10346045
    [No Abstract]   [Full Text] [Related]  

  • 31. Price survey. Paper price swings resist taming.
    Hosp Mater Manage; 2000 Mar; 25(3):1, 14-5. PubMed ID: 10977510
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessing the impact of drug-eluting stents. Hospitals must be prepared to absorb a potentially negative financial impact.
    Pfeiffer H
    Healthc Exec; 2003; 18(4):60-1. PubMed ID: 12841062
    [No Abstract]   [Full Text] [Related]  

  • 33. Price survey. Paper bargains about to end.
    Hosp Mater Manage; 2002 Sep; 27(9):1, 12-3. PubMed ID: 12242872
    [No Abstract]   [Full Text] [Related]  

  • 34. Stent prices starting to retreat.
    Hensley S
    Mod Healthc; 1999 Jul; 29(30):34. PubMed ID: 10539351
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiac relief. Stent prices could drop with FDA approvals ahead.
    Hensley S
    Mod Healthc; 1997 Jul; 27(28):86. PubMed ID: 10168525
    [No Abstract]   [Full Text] [Related]  

  • 36. Paradigm shifts in cardiovascular medicine.
    Holmes DR; Firth BG; Wood DL
    J Am Coll Cardiol; 2004 Feb; 43(4):507-12. PubMed ID: 14975455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compare plant operations and maintenance costs.
    Health Facil Manage; 1995 Aug; 8(8):92-3. PubMed ID: 10144449
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-eluting stents boost prices.
    Hosp Mater Manage; 2004 Jan; 29(1):1, 12-4. PubMed ID: 14768436
    [No Abstract]   [Full Text] [Related]  

  • 39. Negotiating with statistics.
    Page L
    Mater Manag Health Care; 2006 Nov; 15(11):22-6. PubMed ID: 17191552
    [No Abstract]   [Full Text] [Related]  

  • 40. I.V. solution prices remain stable.
    Hosp Mater Manage; 1994 Oct; 19(10):1, 12-3. PubMed ID: 10137917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.